First patient treated in new phase II clinical trial at Radiumhospitalet in Oslo – promising use of Lytix cancer treatment in patients with early-stage melanoma

  Oslo, Norway, November 6, 2024 – Lytix Biopharma, a Norwegian immuno-oncology company dedicated to being part of tomorrow’s cancer

READ MORE

Marwari Catalysts Invites Early-Stage Startups for Thrive 9.0 of Acceleration and Funding Cycle

Marwari Catalysts is excited to announce the opening of applications for Thrive 9.0, the latest batch of its successful acceleration and funding program. This

READ MORE